google analytics

HORIZON TESTING

Horizon is a genetic carrier screening designed for married couples, enabling them to evaluate

the potential risk of transmitting significant genetic anomalies to their offspring. This screening

can be conducted either prior to conception or during pregnancy.

Utilizing cutting-edge technology, which includes next-generation sequencing, Horizon offers a

thorough examination for genes linked to particular hereditary genetic ailments. This encompassing

screening encompasses the analysis of frequently screened conditions such as cystic fibrosis, spinal

muscular atrophy, fragile X syndrome, and sickle cell anemia.

Who should get tested?

● Pairs who wish to undergo carrier testing for their respective genetic disorders.
● Pairs preparing for parenthood.

Key highlight

Conditions Screened For and Package

Genetic carrier screening designed for married couples This screening can be conducted either prior to conception or during pregnancy. Selectable from a comprehensive list of up to 574 symptoms for examination such as : Alpha-Thalassemia (HBA genes), Batten Disease, CLN3-Related (CLN3 gene), Beta-Hemoglobinopathies(HBB gene), Bloom Syndrome (BLM gene), Canavan Disease (ASPA gene), Citrullinemia, Type 1 (ASS1 gene), Cystic Fibrosis (CFTR gene), Duchenne and Becker Muscular Dystrophy (dystrophin gene), Familial Dysautonomia (IKBKAP gene), Fanconi Anemia, Group C (FANCC gene), Fragile X Syndrome (FMR1 gene), Galactosemia (GALT gene), Gaucher Disease (GBA gene), Glycogen Storage Disease-Type 1a (G6PC gene) , Isovaleric Acidemia (IVD gene), Medium Chain Acyl-CoA Dehydrogenase Deficiency(ACADM gene) Methylmalonic Aciduria and Homocystinuria, Type cblC (MMACHC gene), Mucolipidosis, Type IV (MCOLN1 gene), Mucopolysaccharidosis, Type I (IDUA gene), Niemann-Pick Disease-Types A/B (SMPD1 gene)-Polycystic Kidney Disease, Autosomal Recessive (ARPKD, PKHD1 gene),Rhizomelic Chondrodysplasia Punctata, Type 1 (PEX7 gene), Smith-Lemli-Opitz Syndrome (DHCR7 gene), Spinal Muscular Atrophy (SMA, SMN1 gene), Tay-Sachs Disease (HEXA gene), yrosinemia, Type 1 (FAH gene), Zellweger Spectrum Disorders, PEX1-Related (PEX1 gene) etc.

Contact Us

BCC GROUP THAILAND

Call center

02-960-0063,086-306-2084

BCC GROUP THAILAND

Line

@panorama.nipt

วัน - เวลาทำการ : วันจันทร์ - ศุกร์ เวลา 8.30 - 17.30 น.

BCC GROUP THAILAND
บริษัท บางกอก ไซโตเจเนติกซ์ เซ็นเตอร์ จำกัด
บริษัท บีซีซี เมดิคอล กรุ๊ป จำกัด

65/17-18 ซอยวิภาวดีรังสิต 16/6 ถ.วิภาวดีรังสิต แขวงจอมพล เขตจตุจักร กทม. 10900

โทรศัพท์ : 02-690-0063, 086-306-2084 090-907-4230

แฟกซ์ : 02-690-0064

อีเมล : info@bccgroup-thailand.com

แผนผังเว็บไซต์